Association of obesity with hypertension and dyslipidemia in type 2 diabetes mellitus subjects

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 11, Issue 1, 2017, Pages 37-41

  Anari, Razieh ^a   Amani, Reza ^a   Latifi, Seyed Mahmoud ^a   Veissi, Masoud ^a   Shahbazian, Hajieh ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Central obesity; Dyslipidemia; General obesity; Hypertension; T2DM

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ABDOMINAL OBESITY; ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ANTIHYPERTENSIVE THERAPY; ARTICLE; BIOCHEMICAL ANALYSIS; BLOOD PRESSURE MEASUREMENT; BODY FAT; BODY MASS; CALORIC INTAKE; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GROUPS BY AGE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ANTHROPOMETRY; COMPLICATION; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FOLLOW UP; IRAN; METABOLISM; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; RISK FACTOR;

ADULT; AGED; ANTHROPOMETRY; BIOMARKERS; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; IRAN; MALE; MIDDLE AGED; OBESITY; PREVALENCE; PROGNOSIS; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84979740265     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2016.07.004     Document Type: Article

References (40)

1. [1] Nguyen, T., Lau, D.C.W., Obesity epidemic and its impact on hypertension (Review). Can J Cardiol. 28:3 (2012), 326–333.
2. [2] Carr, D.B., Utzschneider, K.M., Hull, R.L., Kodama, K., Retzlaff, B.M., Brunzell, J.D., et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53:8 (2004), 2087–2094.
3. [3] Zimmet, P., Alberti, K.G.M.M., Shaw, J., Global and societal implications of the diabetes epidemic. Nature 414 (2001), 782–787.
4. [4] Carey, V.J., Walters, E.E., Colditz, G.A., Solomon, C.G., Willet, W.C., Rosner, B.A., et al. Body fat distribution and risk of non-insulin dependent diabetes in women: the Nurses' Health Study. Am J Epidemiol 145 (1997), 614–619.
5. [5] Chrostowska, M., Szyndler, A., Paczwa, P., Narkiewicz, K., Impact of abdominal obesity on the frequency of hypertension and cardiovascular disease in Poland—Results from the IDEA study (International Day for the Evaluation of Abdominal Obesity). Blood Press 20:3 (2011), 145–152.
6. [6] American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013 Jan; 36 Suppl. 1:S67-74. PubMed PMID: 23264425. Pubmed Central PMCID: 3537273.
7. [7] Hanefeld, M., Koehler, C., Gallo, S., Benke, I., Ott, P., Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study. Cardiovasc Diabetol, 6, 2007, 13.
8. [8] Song, S.H., Hardisty, C.A., Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity. QJM 101:11 (2008), 875–879.
9. [9] Centers for Disease Control and Prevention (CDC). Prevalence of overweight and obesity among adults with diagnosed diabetes—United States, 1988–1994 and 1999–2002. MMWR Morb Mortal Wkly Rep. 2004; 53:1066–1068. PMID: 15549021.
10. [10] Zhou, X., Ji, L., Ran, X., Su, B., Ji, Q., Pan, C., et al. Prevalence of obesity and its influence on achievement of cardiometabolic therapeutic goals in chinese type 2 diabetes patients: an analysis of the nationwide, cross-Sectional 3 B study. PLoS One, 11(1), 2016, e0144179, 10.1371/journal. pone.0144179.
11. [11] Marjani, A., Prevalence of obesity among type 2 diabetes mellitus in Gorgan (South East of Caspian Sea), Iran. J Chin Clin Med 6:2 (2011), 85–92.
12. [12] Colosia, A.D., Palencia, R., Khan, S., Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review Diabetes. Metab Syndr Obes: Targets Ther 6 (2013), 327–338.
13. [13] Colditz, G.A., Willett, W.C., Rotnitzky, A., Manson, J.E., Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 122 (1995), 481–486.
14. [14] Iribarren, C., Sharp, D.S., Burchfiel, C.M., Petrovitch, H., Association of weight loss and weight fluctuation with mortality among Japanese American men. N Engl J Med 333 (1995), 686–692.
15. [15] Ledoux, M., Lambert, J., Reeder, B.A., Despres, J.P., Correlation between cardiovascular disease risk factors and simple anthropometric measures: canadian Heart Health Surveys Research Group. CMAJ 157 (1997), S46–53.
16. [16] Lemos-Santos, M.G., Valente, J.G., Goncalves-Silva, R.M., Sichieri, R., Waist circumference and waist-to-hip ratio as predictors of serum concentration of lipids in Brazilian men. Nutrition 20 (2004), 857–862.
17. [17] Veissi, M., Anari, R., Amani, R., Shahbazian, H.B., Latifi, S.M., Mediterranean diet and metabolic syndrome prevalence in type 2 diabetes patients in Ahvaz, southwest of Iran,Diab Met Syndr. Clin Res Rev(January), 2016, 10.1016/j.dsx.2016.01.015 pii: S1871-4021(15)30078-3 [Epub ahead of print].
18. [18] Friedewald, W.T.L.R., Fredrickson, D.S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 18 (1972), 499–502.
19. [19] Arai, H., Yamamoto, A., Matsuzawa, Y., Saito, Y., Yamada, N., Oikawa, S., et al. Prevalence of metabolic syndrome in the general japanese population in 2000. J Atheroscler Thromb 13:4 (2006), 202–208.
20. [20] Expert Panel on Detection: Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the third national cholesterol education program expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Panel Treatment III). JAMA 2001; 285:2486–2497.
21. [21] Zimmet, P.Z., Alberti, K.G., Shaw, J., International Diabetes Federation: the IDF consensus worldwide definition of the metabolic syndrome. Diab Voice 50 (2005), 31–33.
22. [22] Buse, J.B., Ginsberg, H.N., Bakris, G.L., Clark, N.G., Costa, F., Eckel, R., et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 115 (2007), 114–126.
23. [23] Kannel, W.B., McGee, D.L., Diabetes and cardiovascular risk factors: the Framingham study. Circulation 59:1 (1979), 8–13.
24. [24] Satoh, H., Kishi, R., Tsutsui, H., Body mass index can similarly predict the presence of multiple cardiovascular risk factors in middle-aged Japanese subjects as waist circumference. Intern Med 49 (2010), 977–982.
25. [25] Shahbazian, H., Latifi, S.M., Jalali, M.T., Shahbazian, H., Amani, R., Nikhoo, A., et al. Metabolic syndrome and its correlated factors in an urban population in South West of Iran. J Diab Metab Disord., 12(1), 2013, 11.
26. [26] Janghorbani, M., Amini, M., Metabolic syndrome in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors. Metab Syndr Relat Disord. 5:3 (2007), 243–254.
27. [27] Kabakov, E., Norymberg, C., Osher, E., Koffler, M., Tordjman, K., Greenman, Y., et al. Prevalence of hypertension in type 2 diabetes mellitus: impact of the tightening definition of high blood pressure and association with confounding risk factors. J Cardiometab Syndr 1:2 (2006), 95–101.
28. [28] Mubarak, F.M., Froelicher, E.S., Jaddou, H.Y., Ajlouni, K.M., Hypertension among 1000 patients with type 2 diabetes attending a national diabetes center in Jordan. Ann Saudi Med 28:5 (2008), 346–351.
29. [29] Ridderstråle, M., Gudbjörnsdottir, S., Eliasson, B., Nilsson, P.M., Cederholm, J., Steering committee of the swedish national diabetes register (NDR): obesity and cardiovascular risk factors in type 2 diabetes: results from the swedish national diabetes register. J Intern Med 259:3 (2006), 314–322.
30. [30] Goel, S., Garg, P.K., Malhotra, V., Madan, J., Mitra, S.K., Grover, S., Dyslipidemia in type II diabetes mellitus − an assessment of the main lipoprotein abnormalities. Bangladesh J Med Sci 15:1 (2016), 99–102.
31. [31] Latifi, S.M., Moradi, L., Shahbazian, H., Aleali, A.M., A study of the prevalence of dyslipidemia among the adult population of Ahvaz, Iran. Diab Metab Syndre: Clin Res Rev(Junuary (8)), 2016 in press.
32. [32] Steinmetz, A., Fenselau, S., Schrezenmeir, J., Treatment of dyslipoproteinemia in the metabolic syndrome. Exp Clin Endocrinol Diab 109 (2001), S548–S559.
33. [33] Robins, S.J., Rubins, H.B., Faas, F.H., Schaefer, E.J., Elam, M.B., Anderson, J.W., et al. Insulin resistance and cardiovascular events with low HDL cholesterol: the veterans affairs HDL intervention trial (VA-HIT). Diab Care 26:5 (2003), 1513–1517.
34. [34] Sonestedt, E., Gullberg, B., Ericson, U., et al. Association between fat intake, physical activity and mortality depending on genetic variation in FTO. Int J Obes (Lond.) 35 (2011), 1041–1049.
35. [35] Pouliot, M.C., Després, J.P., Lemieux, S., Moorjani, S., Bouchard, C., Tremblay, A., et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 73 (1994), 460–468.
36. [36] Koning, L., Merchant, A.T., Pogue, J., Anand, S.S., Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J 28:7 (2007), 850–856.
37. [37] Winter, Y., Rohrmann, S., Linseisen, J., Lanczik, O., Ringleb, P.A., Hebebrand, J., et al. Contribution of obesity and abdominal fat mass to risk of stroke and transient ischemic attacks. Stroke 39 (2008), 3145–3151.
38. [38] Berg, A.H., Scherer, P.E., Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96 (2005), 939–949.
39. [39] Daousi, C., Casson, I.F., Gill, G.V., MacFarlane, I.A., Wilding, J.P., Pinkney, J.H., Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors. Postgrad Med J. 82 (2006), 280–284 PMID: 16597817.
40. [40] American Diabetes Association Standards of medical care in diabetes—2013. Diabetes Care 2013; 36 Suppl. 1: S11–S66.